Plain-English translation of NCT00381121 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects biological samples—blood, urine, and sometimes kidney tissue—from people being treated for kidney disease at the University of Michigan. The goal is to build a resource bank that researchers can use to study the causes of kidney disease and find new ways to prevent and treat it. Your samples help scientists understand how kidney diseases develop and progress.
Most kidney diseases today are not fully understood, and treatments are often generic rather than tailored to the specific cause of a patient's disease. This study exists to create a resource that will help researchers identify the underlying biological reasons why kidney disease happens, so they can develop more effective, personalized prevention and treatment strategies in the future.
You likely qualify if…
You likely don't qualify if…
If you join, your routine clinical care at the University of Michigan's nephrology clinic will remain unchanged. The researchers will collect basic information about your medical history and current condition, take blood and urine samples during your regular visits, and—if your doctor has already recommended a kidney biopsy as part of your standard care—preserve a small tissue sample for research use after the pathology team has completed their evaluation for your medical needs. There is no additional time commitment beyond your regular clinic visits.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
amfAR, The Foundation for AIDS Research, Regeneron Pharmaceuticals
Enrollment target
~420 participants
Started
September 2006
Primary completion
August 2030
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chrysta Lienczewsky
University of Michigan
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.